Sanders Shares Type 1 Diabetes Story With Dexcom U

Basketball guard Shelomi Sanders discussed living with Type 1 diabetes since age 13 in an Instagram post.

Updated on Nov. 18, 2026 in Diabetes

Gouache-painted editorial illustration of a small round sensor disc beside a glass of water on a pale cream surface, in warm ochre and sage tones.
Basketball guard Shelomi Sanders said on Instagram on November 17 that she has lived with Type 1 diabetes since age 13, and that early symptoms were initially mistaken for workout fatigue. AI Illustration. Upload story photo >

Shelomi Sanders, a guard for the women's basketball team at Colorado State University Pueblo, posted an Instagram caption on November 17, 2026, about living with Type 1 diabetes since she was diagnosed at age 13. She has partnered with Dexcom U to raise diabetes awareness.

Why it matters

Sanders's account describes early symptoms of weight loss, excessive thirst and unusual tiredness, which were initially mistaken for workout exertion. Her disclosure highlights how diabetes symptoms can be overlooked, especially in active young people.

The post is a personal account rather than a clinical study, reporting a diagnosis at age 13 and roughly ten years of living with the condition. The source does not provide population statistics or treatment outcome data.

The players

Shelomi Sanders

A guard for the women's basketball team at Colorado State University Pueblo, she has previously played at the Division I level.

Dexcom U

The education arm of Dexcom, a maker of continuous glucose monitoring systems, with which Sanders has partnered to raise diabetes awareness.

The details

Sanders said her early symptoms were initially mistaken for exertion from workouts with Deion Sanders. She later vomited after taking Nyquil and was taken to the emergency room with high blood sugar levels.

Timeline

  1. Age 13: Sanders is diagnosed with diabetes.

  2. November 17, 2026: Sanders posts the Instagram caption about her diagnosis.

Health Landscape

Athlete-led awareness campaigns around continuous glucose monitoring, such as the Dexcom partnership, reflect a broader effort by device makers to reach younger people with Type 1 diabetes. Sanders's account fits a pattern in which personal disclosures are used to highlight early warning signs of the disease.

For people with Type 1 diabetes, the account underscores that unexplained weight loss, excessive thirst and unusual fatigue can signal the condition and warrant prompt medical testing. Continuous glucose monitoring, which Sanders uses overnight, is one tool people with the condition may discuss with their care team.

The takeaway

Unexplained weight loss, excessive thirst and unusual tiredness are warning signs worth checking, even in young, active people. Anyone with those symptoms should ask a doctor about blood sugar testing.

Further reading

Explore more on Diabetes coverage across the United States.

Source note: This article includes information reported by EssentiallySports.